Moreover, potent novel SFN and 6-SFN analogs that modified HAT and HDAC activities also attenuated HR/NHEJ repair mechanisms in colon cancer cells, providing a potential new avenue for chemosensitization [14]. This evidence concerns the gene TMPRSS11D and malignant colon neoplasm.